Ginkgo Bioworks, a cell programming company, claims large addressable markets worth trillions, but its stock has dropped 31% over the past year.
Ginkgo Bioworks (NYSE: DNA), a cell programming company, claims to have large addressable markets in various industries potentially worth trillions. It has partnerships with top businesses and uses AI to enhance operations. However, investors have been unimpressed with the stock, which has dropped 31% over the past year. The company's long-term potential may require significant patience, as markets may take over a decade to reach their full size.
May 18, 2024
3 Articles